Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
The SURMOUNT trials demonstrated sustained weight loss over 68 weeks of continuous tirzepatide therapy, with participants losing up to 22% body weight at the highest doses
Heaney, R
This is the strongest evidence tier available for any melanotan-1 benefit
A longer-term initiative, the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model , will launch in Medicaid as early as May 2026 and in Medicare Part D by January 2027, combining GLP-1 access with evidence-based lifestyle supports ( [68] )
Part B Rev
US$ 25.94
US$ 20.88
US$ 24.28
US$ 25.50
